Generics News
-
Arthritis: Act before it gets Late
Generics | News | 0 Comment | 13 Sep, 2017
Started in 1996, October 12 is recognised as the World Arthritis Day (WAD). Established by Arthritis and Rheumatism International (ARI) and supported by the European League Against Rheumati...Read more
-
Michigan third most preferred destination in Midwest for life science investment
Generics | News | 0 Comment | 11 Sep, 2017
Michigan ranked third among 11 Midwest regions for the value of equity investments made in life sciences companies during the first half of 2017. A midyear report from Cleveland-base...Read more
-
Eli Lilly to invest more in new medicines and drive growth
Generics | News | 0 Comment | 08 Sep, 2017
Eli Lilly and Company has decided to streamline operations to more efficiently focus resources on developing new medicines and to improve its cost structure. Global workforce reductions, in...Read more
-
Lupin launches generic Benicar tablets in the US
Generics | News | 0 Comment | 04 Sep, 2017
Pharma company Lupin Limited has announced the launch of its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg having received an approval from the United States Food and Drug Administrat...Read more
-
U.S. FDA approves chemo group's benznidazole to treat children with Chagas disease
Generics | News | 0 Comment | 01 Sep, 2017
Singapore – The U.S. Food and Drug Administration (FDA) approved Chemo Research's New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat...Read more
-
Battlefield Acupuncture (BFA): New pain management process for the military
Generics | News | 0 Comment | 27 Aug, 2017
Singapore - With the pressing need for more efficient and agile pain management practices for military service personnel, Dr. Richard C. Neimtzow of Andrews Air force base d...Read more
-
Victoza indicated to reduce the risk of three major adverse cardiovascular events
Generics | News | 0 Comment | 26 Aug, 2017
The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events, heart attack, stroke...Read more
-
Generic Seroquel XR tablets launched by Lupin in USA
Generics | News | 0 Comment | 24 Aug, 2017
Lupin Limited has announced the launch of its Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg. The tablet was approval from the United States Food an...Read more
-
Generics | News | 0 Comment | 21 Aug, 2017
Singapore – US FDA has granted two orphan drug designations (ODD) for T cell therapy products to Singapore-based biotech company, Lion TCR Pte Ltd, for the treatment of hepatocel...Read more
-
FDA provides new tools for tests to detect Zika virus infection
Generics | News | 0 Comment | 18 Aug, 2017
Singapore- As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid ...Read more
-
Bruker announces US FDA clearance of expanded 3rd claim for MALDI Biotyper
Generics | News | 0 Comment | 01 Aug, 2017
Singapore – Bruker, a US based manufacturing company of scientific instruments announced that it has received US Food & Drug Administration (FDA) clearance for its third, further ...Read more
-
LEO Pharma gets EC nod for its first and only biologic Kyntheum that targets the IL-17 receptor
Generics | News | 0 Comment | 26 Jul, 2017
LEO Pharma announced that the European Commission has granted marketing authorization for Kyntheum (brodalumab), a new biologic for the treatment of moderate-to-severe plaque psoriasis in a...Read more
-
Merck wins tentative U.S. FDA approval for Lusduna
Generics | News | 0 Comment | 26 Jul, 2017
Merck announced in a press release that the U.S. Food and Drug Administration (FDA) has granted tentative approval for LUSDUNA Nexvue (insulin glargine injection) 100 units/mL, a ...Read more
-
Study suggests positive airway pressure therapy could reduce COPD patient hospitalizationsÂ
Generics | News | 1 Comment | 11 Jul, 2017
Singapore - COPD hospitalizations are at an all-time high. The 30-day readmission rate for patients ranges from 20-39 percent, with related healthcare costs at an estimated $50 billion...Read more
-
Japanese regulators grant additional approval for the sale of Ipsen's rare cancer drug in Japan
Generics | News | 1 Comment | 04 Jul, 2017
Bringing in much needed relief for millions of gastroenteropancreatic neuroendocrine cancer patients, the Japanese regulators have approved the sale of the drug Somatuline by Teijin pharma ...Read more
-
Taiwan Pharma Association opens new office in Malaysia
Generics | News | 0 Comment | 09 Jun, 2017
Singpaore: In a bid to strengthen trade between two countries, the Taiwan Pharmaceutical Manufacturer’s Association has opened a New Southbound office in Kuala Lumpur, Malaysia. The a...Read more
-
Astellas prostrate cancer drug gets EU nod
Generics | News | By BioSpectrum Bureau | 0 Comment | 25 Jun, 2013
Singapore: The European Commission has approved Xtandi (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer, whose disease has progressed on...Read more
-
Sanofi, Carlyle to buy Elder Pharma for $450 mn
Generics | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: Sanofi's India unit and Carlyle group are in talks to buy the domestic drug formulation business of Indian drug major Elder Pharmaceuticals in a deal worth $400-to-450 million, a...Read more
